Everolimus

Everolimus, a selective mTOR (mammalian target of rapamycin) inhibitor, belongs to a class of medications called immunosuppressants. This means it helps to reduce the immune system’s activity, preventing the body from attacking healthy cells. Everolimus is used primarily in combination with other medications to treat people with a specific type of kidney disease called focal segmental glomerulosclerosis, which is characterized by damage to the glomeruli, the filtering units in the kidneys. Additionally, Everolimus is utilized for preventing organ rejection in people who have undergone kidney, liver, or heart transplantations. By suppressing the immune response, Everolimus can help to maintain the health and functionality of transplanted organs.
Everolimus is usually administered orally and requires regular monitoring by a healthcare professional to ensure its effectiveness and minimize any side effects. As with any medication, patients should consult with their doctors if they experience any adverse reactions, allergies, or interactions with other medications. Ensuring patient safety and maintaining optimal health outcomes are of the utmost importance when using Everolimus.